Osteoinductive biomaterials for medical implantation

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Current bone implants have significant drawbacks, necessitating the development of improved materials.
• Allogeneic demineralized bone implants exhibit considerable resorption, impacting long-term efficacy.
• Factors influencing demineralized bone implant efficacy include implantation site and preparation method.

Purpose of the Study:

• To evaluate the bone-inducing potential of demineralized bone implants, modified with growth factors.
• To assess the efficacy of transforming growth factor-beta 1 (TGF-beta 1) combined with demineralized bone powder.
• To investigate the bone-inducing capacity of osteoinductive factor extract (OFE) in a facial augmentation model.

Main Methods:

• Review of clinical follow-up data for 75 allogeneic demineralized bone implants.
• Experimental combination of recombinant TGF-beta 1 with demineralized bone powder in a rabbit facial augmentation model.
• Implantation of OFE using a collagen/ceramic carrier in a rabbit facial augmentation model, followed by histomorphometry.

Main Results:

• Allogeneic demineralized bone implants showed significant resorption (49% average, increasing to 82.5% for nasal augmentation at 24 months).
• Implants with TGF-beta 1 demonstrated increased bone formation at 6 weeks but remained suboptimal.
• OFE implants in rabbits showed significant bone formation and numerous osteoblasts at 21 days.

Conclusions:

• Demineralized bone implants face challenges with resorption, limiting their ideal application.
• While TGF-beta 1 enhances bone formation, it does not fully resolve suboptimal bone-inducing activity.
• OFE shows promise for bone induction, likely due to Bone Morphogenetic Protein-2A (BMP-2A), highlighting the potential of recombinant factors.
• Development of effective carriers for recombinant bone-inducing factors is crucial for future applications.